GHALIE RICHARD G 4
4 · MEI Pharma, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GHALIE RICHARD G
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-01+320,000→ 320,000 totalExercise: $2.95Exp: 2031-07-01→ Common Stock (320,000 underlying)
Holdings
- 150,000
Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (150,000 underlying) - 75,000
Stock Option (Right to Buy)
Exercise: $3.55Exp: 2031-05-03→ Common Stock (75,000 underlying) - 65,000
Stock Option (Right to Buy)
Exercise: $2.88Exp: 2027-07-07→ Common Stock (65,000 underlying) - 150,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (150,000 underlying) - 130,000
Stock Option (Right to Buy)
Exercise: $1.21Exp: 2026-03-07→ Common Stock (130,000 underlying) - 25,000
Stock Option (Right to Buy)
Exercise: $1.38Exp: 2026-07-14→ Common Stock (25,000 underlying) - 130,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (130,000 underlying)
Footnotes (7)
- [F1]One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
- [F2]All options are currently exercisable.
- [F3]One-quarter of such options vested on July 7, 2018, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 7, 2018.
- [F4]One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
- [F5]One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
- [F6]One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
- [F7]One-quarter of such options shall vest on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.